NCT05945888View on ClinicalTrials.gov

A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Healthy
Interventions
DRUG

BI 3000202

BI 3000202

DRUG

Placebo matching BI 3000202

Placebo matching BI 3000202

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05945888 - A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood | Biotech Hunter | Biotech Hunter